Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Theravance Inc
Theravance Inc_20100128
Theravance Inc_20131212
  

Theravance Inc patents

Recent patent applications related to Theravance Inc. Theravance Inc is listed as an Agent/Assignee. Note: Theravance Inc may have other listings under different names/spellings. We're not affiliated with Theravance Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "T" | Theravance Inc-related inventors




Date Theravance Inc patents (updated weekly) - BOOKMARK this page
11/06/143-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
09/25/14Crystalline forms of a biphenyl compound
09/25/148-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
09/18/14Hydrochloride salts of an antibiotic compound
09/18/14Crystalline form of a substituted thiazolylacetic acid triethylamine salt
09/11/14Neprilysin inhibitors
09/11/14Crystalline form of a quinolinone-carboxamide compound
08/28/14Serotonin reuptake inhibitors
08/21/14Biphenyl derivatives
07/10/14Dual-acting oxazole antihypertensive agents
06/19/14Biphenyl compounds useful as muscarinic receptor antagonists
06/12/14Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
05/15/14Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents
05/01/14Process for preparing a biphenyl-2-ylcarbamic acid
05/01/14Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound
04/17/14Dual-acting benzoimidazole antihypertensive agents
03/20/148-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
03/20/14Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
03/13/14Neprilysin inhibitors
02/27/145-ht4 receptor agonist compounds for treatment of cognitive disorders
02/27/144-[2-(2-fluorophenoxy methyl)phenyl]piperidine compounds
02/20/14Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
02/13/14Crystalline form of a 4-[2-(2-fluorophenoxymethyl) phenyl]piperidine compound
02/13/14Neprilysin inhibitors
02/13/14Dual-acting antihypertensive agents
01/30/143-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
01/23/14Glycopeptide phosphonate derivatives
01/23/14Dual-acting antihypertensive agents
01/16/14Crystalline form of a 3-phenoxymethylpyrrolidine compound
01/09/14Neprilysin inhibitors
12/26/13Process for preparing biphenyl imidazole compounds
12/26/13Crystalline forms of a 3-carboxypropyl-aminotetralin compound
12/19/13Crystalline freebase forms of a biphenyl compound
12/12/13Diamide compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
12/05/131-(2-phenoxymethylheteroaryl) piperidine and piperazine compounds
11/07/13Serotonin reuptake inhibitors
10/31/13Crystalline form of a biphenyl compound
10/24/13Quaternary ammonium compounds useful as muscarinic receptor antagonists
10/17/13Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
10/17/13Biphenyl compounds useful as muscarinic receptor antagonists
10/10/13Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents
10/10/13Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
10/03/13Neprilysin inhibitors
09/26/13Serotonin reuptake inhibitors
09/19/13Neprilysin inhibitors
09/12/133-phenoxymethylpyrrolidine compounds
08/15/13Dual-acting antihypertensive agents
07/11/133-(phenoxyphenylmethyl)pyrrolidine compounds
07/04/13Biphenyl compounds useful as muscarinic receptor antagonists
06/20/138-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
06/13/13Biphenyl derivatives
05/30/13Diamide compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
05/23/13Crystalline forms of a biphenyl compound
05/02/13Methods for detecting sulfhydryl-containing compounds in a biological test sample
03/28/13Process for preparing an intermediate to mu opioid receptor antagonists
03/21/13Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
03/14/13Crystalline forms of a 3-carboxypropyl-aminotetralin compound
02/14/13Aminotetralin compounds as mu opioid receptor antagonists
02/07/133-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
01/31/134-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
01/31/13Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
12/06/12Neprilysin inhibitors
12/06/12Neprilysin inhibitors
12/06/12Neprilysin inhibitors
12/06/12Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
Patent Packs
12/06/123-phenoxymethylpyrrolidine compounds
11/08/12Glycopeptide phosphonate derivatives
11/08/12Crystalline form of a biphenyl compound
11/01/12Amidine-containing compounds useful as muscarinic receptor antagonists
11/01/12Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
10/18/12Methods for detecting sulfhydryl-containing compounds in a biological test sample
10/18/12Dual-acting antihypertensive agents
10/18/12Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
10/11/12Dual-acting antihypertensive agents
10/11/12Dual-acting pyrazole antihypertensive agents
09/20/12Dual-acting benzoimidazole antihypertensive agents
09/13/12Quaternary ammonium compounds useful as muscarinic receptor antagonists
08/30/12Guanidine-containing compounds useful as muscarinic receptor antagonists
08/23/12Neprilysin inhibitors
08/23/12Neprilysin inhibitors
Patent Packs
08/23/12Dual-acting antihypertensive agents
08/23/12Cross-linked glycopeptide-cephalosporin antibiotics
08/16/12Process for preparing biphenyl imidazole compounds
07/26/12Biphenyl compounds useful as muscarinic receptor antagonists
07/12/12Crystalline form of a 3-phenoxymethylpyrrolidine compound
06/28/12Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
06/28/12Dual-acting imidazole antihypertensive agents
06/21/12Neprilysin inhibitors
06/21/12Neprilysin inhibitors
06/07/12Serotonin reuptake inhibitors
05/24/12Dual-acting antihypertensive agents
05/17/12Biphenyl compounds useful as muscarinic receptor antagonists
05/17/12Biphenyl compounds useful as muscarinic receptor antagonists
05/10/12Novel inhibitors of hepatitis c virus
05/10/12Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
04/12/123-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
04/12/12Aminotetralin compounds as mu opioid receptor antagonists
04/12/12Serotonin reuptake inhibitors
04/12/12Crystalline forms of a 3-carboxypropyl-aminotetralin compound
04/12/12Dual-acting antihypertensive agents
04/05/12Crystalline oxalate salts of a diamide compound
03/22/12Aryl aniline derivatives as beta2 adrenergic receptor agonists
12/29/11Guanidine-containing compounds useful as muscarinic receptor antagonists
12/29/11Biphenyl compounds useful as muscarinic receptor antagonists
12/22/11Biphenyl derivatives
12/01/11Amidine-containing compounds useful as muscarinic receptor antagonists
11/17/11Biphenyl compounds useful as muscarinic receptor antagonists
11/17/11Dual-acting antihypertensive agents
11/10/11Dual-acting pyrazole antihypertensive agents
11/10/113-(phenoxyphenylmethyl)pyrrolidine compounds
Social Network Patent Pack
10/20/113-phenoxymethylpyrrolidine compounds
10/20/11Process for purifying glycopeptide phosphonate derivatives
10/13/11Dual-acting antihypertensive agents
09/22/11Dual-acting antihypertensive agents
09/15/11Cross-linked glycopeptide-cephalosporin antibiotics
09/15/11Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
08/18/11Guanidine-containing compounds useful as muscarinic receptor antagonists
08/18/11Crystalline form of a benzimidazole-carboxamide medicinal compound
08/18/11[4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1h-indol-3-yl]-methanone as an inhibitor of mast cell tryptase
07/28/11Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
Patent Packs
07/07/11Process for preparing an intermediate to mu opioid receptor antagonists
06/16/11Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
06/02/11Biphenyl compounds useful as muscarinic receptor antagonists
05/26/11Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
05/19/118-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
04/21/11Dual-acting imidazole antihypertensive agents
04/14/11Crystalline forms of a dimethylphenyl compound
03/24/11Biphenyl compounds useful as muscarinic receptor antagonists
03/10/11Biphenyl compounds useful as muscarinic receptor antagonists
03/10/11Process for preparing glycopeptide phosphonate derivatives
02/10/11Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
01/27/11Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
01/27/11Dual-acting antihypertensive agents
01/27/11Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
01/20/11Diarylmethyl and related compounds
12/30/10Biphenyl compounds useful as muscarinic receptor antagonists
12/09/10Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
11/18/10Indazole-carboxamide compounds
10/21/10Dual-acting antihypertensive agents
10/14/10Indazole-carboxamide compounds as 5-ht4 receptor agonists
10/07/10Crystalline forms of a biphenyl compound
09/30/10Biphenyl compounds useful as muscarinic receptor antagonists
08/05/10Cross-linked glycopeptide-cephalosporin antibiotics
08/05/10Biphenyl compounds useful as muscarinic receptor antagonists
08/05/10Crystalline form of a quinolinone-carboxamide compound
08/05/10Azabicycloalkane compounds
06/24/10Glycopeptide phosphonate derivatives
06/17/10Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
06/03/10Biphenyl compounds useful as muscarinic receptor antagonists
06/03/10Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
Patent Packs
05/20/10Biphenyl compounds useful as muscarinic receptor antagonists
05/20/10Crystalline form of a beta2 adrenergic receptor agonist
05/06/10Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same
04/15/10Biphenyl compounds useful as muscarinic receptor antagonists
04/08/10Aryl aniline derivatives as beta2 adrenergic receptor agonists
03/11/10Biphenyl compounds useful as muscarinic receptor antagonists
03/04/10Biphenyl compounds useful as muscarinic receptor antagonists
02/25/10Crystalline forms of a biphenyl compound
02/18/10Biphenyl compounds useful as muscarinic receptor antagonists
02/11/108-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
02/04/10Crystalline form of a benzimidazole-carboxamide medicinal compound
01/28/10Crystalline forms of a biphenyl compound
10/08/09Short-acting sedative hypnotic agents for anesthesia and sedation
09/24/09Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
09/10/09Biphenyl compounds useful as muscarinic receptor antagonists
04/09/09Dual-acting antihypertensive agents
03/12/09Guanidine-containing compounds useful as muscarinic receptor antagonists
03/05/09Disubstituted alkyl-8-azabicyclo[3.2.1] octane compounds as mu opioid receptor antagonists
03/05/09Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
03/05/09Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
Social Network Patent Pack
12/12/13Diamide compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
01/28/10Crystalline forms of a biphenyl compound







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Theravance Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Theravance Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';